Additional file 1: of Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer

Abstract

Table S1. Oligonucleotides for QM-MSP. (DOC 37 kb

    Similar works

    Full text

    thumbnail-image

    Available Versions